P2RY12 and atrial fibrillation: The ESC guidelines for the management of AF suggest that dual antiplatelet therapy (DAPT, i.e. acetylsalicylic acid + P2Y12 inhibitor) is indicated in patients using oral anticoagulation in whom a PCI is performed.